Chakraborty, R., Yan, Y., & Royal, M. (2021). A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients with Relapsed or Refractory Multiple Myeloma. Blood, 138(Supplement 1), 4763–4763. https://doi.org/10.1182/blood-2021-150783

Love, C., Pillai, R., Ondrejka, S. L., Bhagat, G., Chadburn, A., McKinney, M., Koff, J. L., Soliman, D. S., Czader, M., Louissaint, A., Li, S., Ong, C. K., Behdad, A., Evens, A. M., Natkunam, Y., Norgaard, P. H., Leppa, S., Tse, E., Chapman, J. R., … Dave, S. (2021). The Atlas of Blood Cancer Genomes (ABCG) Project: A Comprehensive Molecular Characterization of Leukemias and Lymphomas. Blood, 138(Supplement 1), 2213–2213. https://doi.org/10.1182/blood-2021-151346

Chen, S., Dershowitz, L., & George, I. (2021). Transcatheter valve implantation for degenerated tricuspid bioprosthesis and failed tricuspid ring. Annals of Cardiothoracic Surgery, 10(5), 651–657. https://doi.org/10.21037/acs-2021-tviv-11

Ricker, E. C., Ryu, Y. K., & Amengual, J. E. (2021). Daratumumab Plus Chemotherapy Induces Complete Responses in a Consecutive Series of Four Patients with Plasmablastic Lymphoma. Blood, 138(Supplement 1), 4573–4573. https://doi.org/10.1182/blood-2021-150800

Mathew, J., Cerpa, M., Lee, N. J., Boddapati, V., Marciano, G., Sardar, Z. M., & Lenke, L. G. (2021). Comparing hyperlordotic and standard lordotic cages for achieving segmental lumbar lordosis during transforaminal lumbar interbody fusion in adult spinal deformity surgery. Journal of Spine Surgery, 7(3), 318–325. https://doi.org/10.21037/jss-21-15

Li, S., Fu, J., Yang, J., Ma, H., Mapara, M. Y., Marcireau, C., & Lentzsch, S. (2021). MAP4K2 Silencing Overcomes IMiDs-Resistance in Multiple Myeloma. Blood, 138(Supplement 1), 2662–2662. https://doi.org/10.1182/blood-2021-151844

Sun, D., Richard, M. A., Musani, S. K., Sung, Y. J., Winkler, T. W., Schwander, K., Chai, J. F., Guo, X., Kilpeläinen, T. O., Vojinovic, D., Aschard, H., Bartz, T. M., Bielak, L. F., Brown, M. R., Chitrala, K., Hartwig, F. P., Horimoto, A. R. V. R., Liu, Y., Manning, A. K., … Fornage, M. (2021). Multi-ancestry genome-wide association study accounting for gene-psychosocial factor interactions identifies novel loci for blood pressure traits. Human Genetics and Genomics Advances, 2(1), 100013. https://doi.org/10.1016/j.xhgg.2020.100013

De Botton, S., Yee, K., Recher, C., Wei, A. H., Montesinos, P., Taussig, D., Pigneux, A., Braun, T., Curti, A., Esteve, J., Grove, C., Jonas, B. A., Khwaja, A., Legrand, O., Peterlin, P., Arnan Sangerman, M., Blum, W. G., Cilloni, D., Hiwase, D., … Fenaux, P. (2021). Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia. Blood, 138(Supplement 1), 2351–2351. https://doi.org/10.1182/blood-2021-144912

Eckhardt, C. M., & Wu, H. (2021). Environmental Exposures and Lung Aging: Molecular Mechanisms and Implications for Improving Respiratory Health. Current Environmental Health Reports, 8(4), 281–293. https://doi.org/10.1007/s40572-021-00328-2

Au Yeung, K. H. R., Russell, V., Choi, W., Wong, A., Tsui, L., Lee, Y. Y. C., Li, J., Gill, H., Ip, H.-W., Kwong, Y. L., Dave, T., Ondrejka, S. L., Bhagat, G., Chadburn, A., Rutherford, S. C., Koff, J. L., Jaye, D. L., Czader, M., Louissaint, A., … Tse, E. (2021). ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis. Blood, 138(Supplement 1), 2403–2403. https://doi.org/10.1182/blood-2021-148807

Scuoppo, C., Cai, B., Ofori, K., Scholze, H., Basso, K., Pasqualucci, L., & Dalla-Favera, R. (2021). Repurposing NAD Salvage Inhibitors for GCB Diffuse Large-B Cell Lymphoma. Blood, 138(Supplement 1), 789–789. https://doi.org/10.1182/blood-2021-151079

Pemmaraju, N., Cuglievan, B., Lasky, J. L., Kheradpour, A., Hijiya, N., Stein, A. S., & Pawlowska, A. B. (2021). Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in Pediatric Patients with Tagraxofusp, a CD123-Targeted Therapy. Blood, 138(Supplement 1), 2317–2317. https://doi.org/10.1182/blood-2021-150393

Prockop, S., Mahadeo, K. M., Beitinjaneh, A., Choquet, S., Stiff, P., Reshef, R., Satyanarayana, G., Dahiya, S., Parmar, H., Ye, W., Gamelin, L., & Dinavahi, R. (2021). Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE). Blood, 138(Supplement 1), 301–301. https://doi.org/10.1182/blood-2021-147274

Paolino, J. D., Harris, M. H., Stevenson, K. E., Koch, V., Cole, P. D., Gennarini, L. M., Kahn, J. M., Kelly, K. M., Kirsch, Ii., Michon, B., Place, A. E., Tran, T. H., Welch, J. J. G., & Silverman, L. B. (2021). Performance of Next Generation Sequencing for Minimal Residual Disease Detection for Pediatric Patients with Acute Lymphoblastic Leukemia: Results from the Prospective Clinical Trial DFCI 16-001. Blood, 138(Supplement 1), 3485–3485. https://doi.org/10.1182/blood-2021-152369

Thompson, M. C., Roeker, L. E., Coombs, C. C., Jensen, J. L., Kamdar, M., Skarbnik, A., Pagel, J. M., Bailey, N., Pu, J. J., Jacobs, R., Hill, B. T., Brander, D. M., Shadman, M., Ujjani, C. S., Battiato, K. E., Komari, C. J., Sacchi De Camargo Correia, G., Aronson, J. H., Rhodes, J. M., … Mato, A. R. (2021). Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton’s Tyrosine Kinase Inhibitor and Venetoclax. Blood, 138(Supplement 1), 2628–2628. https://doi.org/10.1182/blood-2021-150751

Ricker, E. C., Estrella, B., Pazos, M. A., & Amengual, J. E. (2021). Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL. Blood, 138(Supplement 1), 2410–2410. https://doi.org/10.1182/blood-2021-153460

Li Bassi, G., Suen, J. Y., White, N., Dalton, H. J., Fanning, J., Corley, A., Shrapnel, S., Hinton, S., Forsyth, S., Parsons, R., Laffey, J. G., Fan, E., Bartlett, R., Brodie, D., Burrell, A., Chiumello, D., Elhazmi, A., Grasselli, G., … Hodgson, C. (2021). Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019: An International Cohort Study. Critical Care Explorations, 3(11), e0567. https://doi.org/10.1097/cce.0000000000000567

Neelapu, S. S., Chavez, J. C., Sehgal, A. R., Epperla, N., Ulrickson, M. L., Bachy, E., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Oluwole, O. O., Yakoub-Agha, I., Khanal, R., Rosenblatt, J. D., Sherman, M., Dong, J., Giovanetti, A., … Jacobson, C. (2021). Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL). Blood, 138(Supplement 1), 93–93. https://doi.org/10.1182/blood-2021-148473

Kadia, T. M., Pemmaraju, N., Yilmaz, M., Daver, N., Li, L., Lyu, M.-A., Huang, M., Zeng, K., Cook, R., Parmar, S., Mukherjee, S., Sadeghi, T., DiNardo, C. D., Issa, G. C., Jabbour, E. J., Borthakur, G., Jain, N., & Verstovsek, S. (2021). Adoptive Therapy with Allogeneic Cord Blood T Regulatory Cells Improves Transfusion Requirement in Bone Marrow Failure Syndromes. Blood, 138(Supplement 1), 3875–3875. https://doi.org/10.1182/blood-2021-153864

Lue, J. K., Ma, H., Marchi, E., Spivack, J. H., & O’Connor, O. A. (2021). Peripheral T-Cell Lymphoma Involvement of the Central Nervous System: Impact of Novel Therapeutics on Clinical Outcomes. Blood, 138(Supplement 1), 2469–2469. https://doi.org/10.1182/blood-2021-144933

Gru, A. A., Snowden, C., Williams, E., Barrionuevo, C., Sanches, J., Battistella, M., Mo, S., Pulitzer, M., Bhagat, G., Servitje, O., Miyashiro, D., Climent, F., Dueñas, D., Casavilca, S., Guyton-Ringbloom, Ki., Beltran, B. E., Castro, D., Toomey, N. L., Barreto, L., … Ramos, J. C. (2021). Notable Patterns in the Genomic Landscape of Adult T-Cell Leukemia/Lymphoma Encountered in HTLV-1 Endemic Western World Regions. Blood, 138(Supplement 1), 810–810. https://doi.org/10.1182/blood-2021-154275

Arnold, S. D., Bakshi, N., Chang, Z., Ross, D., Abraham, A., Bhatia, M., Guilcher, G. M. T., Haight, A., Hsieh, M., Kasow, K. A., Lane, P. A., Meacham, L., Olowoselu, F. O., & Krishnamurti, L. (2021). Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR). Blood, 138(Supplement 1), 425–425. https://doi.org/10.1182/blood-2021-154280

Park, J. H., Nikiforow, S., Kim, S., Hu, Z.-H., Moskop, A., Ahmed, S., Bilal Abid, M., Badar, T., Bredeson, C., Brown, V., Cairo, M. S., Díaz, M., Dholaria, B., Ganguly, S., Grover, N. S., Hanna, R., Hematti, P., Kohorst, M. A., Lazarus, H., … Perales, M.-A. (2021). Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL). Blood, 138(Supplement 1), 3880–3880. https://doi.org/10.1182/blood-2021-148652

Kitamoto, T., Kuo, T., Okabe, A., Kaneda, A., & Accili, D. (2021). An integrative transcriptional logic model of hepatic insulin resistance. Proceedings of the National Academy of Sciences, 118(45). https://doi.org/10.1073/pnas.2102222118

Veludhandi, A., John, T. D., Bakshi, N., Arnold, S. D., Bhatia, M., Lane, P. A., Meacham, L., Khemani, K., Chaudhury, S., Olowoselu, F. O., Kasow, K. A., Hsieh, M., Abraham, A., Guilcher, G. M. T., & Krishnamurti, L. (2021). Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR). Blood, 138(Supplement 1), 3030–3030. https://doi.org/10.1182/blood-2021-152383

Zhou, T., Guan, R., Rosenthal, S. L., Moerdler, S., Guan, Z., & Sun, L. (2021). Supporting Health-Care Workers and Patients in Quarantine Wards: Evidence From a Survey of Frontline Health-Care Workers and Inpatients With COVID-19 in Wuhan, China. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.705354

Wang, M., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Jurczak, W., Tan, X. N., Lewis, K., Fenske, T. S., Coombs, C. C., Flinn, I. W., Lewis, D. J., Le Gouill, S., Palomba, M. L., Woyach, J. A., Pagel, J. M., Lamanna, N., Cohen, J. B., … Cheah, C. Y. (2021). Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study. Blood, 138(Supplement 1), 381–381. https://doi.org/10.1182/blood-2021-149138

Lee, N. J., Khan, A., Lombardi, J. M., Boddapati, V., Park, P. J., Mathew, J., Leung, E., Mullin, J. P., Pollina, J., & Lehman, R. A. (2021). The accuracy of robot-assisted S2 alar-iliac screw placement at two different healthcare centers. Journal of Spine Surgery, 7(3), 326–334. https://doi.org/10.21037/jss-21-14

Paolino, J. D., Flamand, Y., Stevenson, K. E., Koch, V., Athale, U. H., Cole, P. D., Gennarini, L. M., Kahn, J. M., Kelly, K. M., Laverdiere, C., Leclerc, J.-M., Michon, B., Place, A. E., Supko, J. G., Tran, T. H., Welch, J. J. G., Neuberg, D. S., Sallan, S. E., Silverman, L. B., & Vrooman, L. M. (2021). Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium. Blood, 138(Supplement 1), 3396–3396. https://doi.org/10.1182/blood-2021-151313

Chiu, L., Shen, M., Lo, C.-H., Chiu, N., Chen, A., Shin, H. J., Prsic, E. H., Hur, C., Chow, R., & Lebwohl, B. (2021). Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis. PLOS ONE, 16(11), e0259514. https://doi.org/10.1371/journal.pone.0259514

Koffman, Dr. B., Stewart, C., Avruch, L., Bailey, N., Brumble, R., Byrd, J. C., Danilov, A. V., Davids, M. S., Furman, R., Jain, N., Kay, N. E., Lamanna, N., Mato, A. R., Skarbnik, A., Ujjani, C. S., & Pagel, J. M. (2021). Awareness, Knowledge, and Preferences of United States (US) Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration (FD) Therapy and Minimal (Measurable) Residual Disease (MRD). Blood, 138(Supplement 1), 1927–1927. https://doi.org/10.1182/blood-2021-145046

Hopson, M., Bhutani, D., Sarkaria, S. M., Maurer, M., Griffin, J., Lentzsch, S., & Chakraborty, R. (2021). Impact of Light Chain Isotype on Clinical Features and Outcomes in Systemic AL Amyloidosis. Blood, 138(Supplement 1), 4726–4726. https://doi.org/10.1182/blood-2021-149299

Askew, M., Smaldone, A., Gold, M. A., Smith-Whitley, K., Strouse, J. J., Jin, Z., & Green, N. S. (2021). National Survey of Pediatric Sickle Cell Providers on Their Contraceptive Practices for Female Patients. Blood, 138(Supplement 1), 1898–1898. https://doi.org/10.1182/blood-2021-154083

Chakraborty, R., Rybicki, L. A., Preussler, J. M., Devine, S., Baker, K. S., Syrjala, K., Yi, J. C., Whitten, J. L., Shaw, B. E., & Majhail, N. S. (2021). Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: Secondary Analysis of Two Randomized Controlled Trials on Survivorship Care Plans. Blood, 138(Supplement 1), 431–431. https://doi.org/10.1182/blood-2021-149281

Santini, V., Fenaux, P., Van Eygen, K., Raza, A., Germing, U., Font, P., Diez-Campelo, M., Thepot, S., Vellenga, E., Patnaik, M. M., Jang, J. H., Sherman, L., Berry, T., Feller, F., Dougherty, S., Sun, L., Wan, Y., Rizo, A., Huang, F., & Platzbecker, U. (2021). On-Target Activity of Imetelstat Correlates with Clinical Benefits, Including Overall Survival (OS), in Heavily Transfused Non-Del(5q) Lower Risk MDS (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs). Blood, 138(Supplement 1), 2598–2598. https://doi.org/10.1182/blood-2021-148876

Zonder, J. A., Richter, J., Bumma, N., Brayer, J., Hoffman, J. E., Bensinger, W. I., Wu, K. L., Xu, L., Chokshi, D., Boyapati, A., Sharma, M., Rodriguez Lorenc, K., Kroog, G. S., Dhodapkar, M. V., Lentzsch, S., Cooper, D., & Jagannath, S. (2021). Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood, 138(Supplement 1), 160–160. https://doi.org/10.1182/blood-2021-144921

Garcia, J. S., Wei, A. H., Jacoby, M. A., Fong, C. Y., Borate, U., Baer, M. R., Cunningham, I., Odenike, O., Jurcic, J. G., Nowak, D., Peterlin, P., Platzbecker, U., Dunshee, D., Zhou, Y., Hoffman, D., Sun, Y., Popovic, R., Ainsworth, B., Naqvi, K., … Garcia-Manero, G. (2021). Molecular Responses Are Observed across Mutational Spectrum in Treatment-Naïve Higher-Risk Myelodysplastic Syndrome Patients Treated with Venetoclax Plus Azacitidine. Blood, 138(Supplement 1), 241–241. https://doi.org/10.1182/blood-2021-145613

Lentzsch, S., Lipe, B., Tuchman, S. A., Bahlis, N. J., Bensinger, W. I., Sebag, M., Sutherland, H. J., Monge, J., Gasparetto, C. J., Baljevic, M., Callander, N. S., Venner, C. P., White, D. J., Kotb, R., Chen, C. I., Schiller, G. J., Madan, S., Leblanc, R., DeCastro, A., … Biran, N. (2021). Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb). Blood, 138(Supplement 1), 1651–1651. https://doi.org/10.1182/blood-2021-150232

Albitar, M., Zhang, H., Goy, A. H., Xu-Monette, Z., Bhagat, G., Visco, C., Tzankov, A., Fang, X., Zhu, F., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Huh, J., Ponzoni, M., Ferreri, A. J. M., Moller, M., … Young, K. H. (2021). Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms. Blood, 138(Supplement 1), 2395–2395. https://doi.org/10.1182/blood-2021-148841

Youn, M., Smith, S. M., Lee, A. G., Chae, H.-D., Spiteri, E., Erdmann, J., Galperin, I., Murphy, L. C., Donato, M., Abidi, P., Bittencourt, H., Lacayo, N. J., Dahl, G., Aftandilian, C., Davis, K. L., Matthews, J. A., Kornblau, S. M., Huang, M., Sumarsono, N., … Sakamoto, K. M. (2021). Gene Expression Analysis of CML Patients across the Age Spectrum. Blood, 138(Supplement 1), 1473–1473. https://doi.org/10.1182/blood-2021-148701

Leeman-Neill, R. J., Thakkar, D., Ondrejka, S. L., Hsi, E. D., Chadburn, A., Mejia Saldarriaga, M., Rutherford, S. C., McCall, C. M., Aljurf, T., McKinney, M., Koff, J. L., Jaye, D. L., Cohen, J. B., Soliman, D. S., Louissaint, A., Ong, C. K., Cheng, C. L., Lee, L., Behdad, A., … Bhagat, G. (2021). Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma. Blood, 138(Supplement 1), 2398–2398. https://doi.org/10.1182/blood-2021-149745

Tisdale, J. F., Thompson, A. A., Mapara, M. Y., Kwiatkowski, J. L., Krishnamurti, L., Aygun, B., Kasow, K. A., Rifkin-Zenenberg, S., Schmidt, M., Pierciey, F. J., Whitney, D., Rogers, C., Nnamani, M., Foos, M., Miller, A., Zhang, X., Lynch, J., Walters, M. C., Kanter, J., & Bonner, M. (2021). Polyclonality Strongly Correlates with Biological Outcomes and Is Significantly Increased Following Improvements to the Phase 1/2 HGB-206 Protocol and Manufacturing of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy (GT). Blood, 138(Supplement 1), 561–561. https://doi.org/10.1182/blood-2021-147760

Lee, H. J., Choi, M., Siddiqi, T., Barrientos, J., Wierda, W. G., Isufi, I., Tuscano, J., Lamanna, N., Subbiah, S., Koff, J. L., Leslie, L. A., Goldenberg, A., Chung, G. G., Breitmeyer, J. B., Yazji, S., Wang, Y., Wang, M., Jamieson, C., & Kipps, T. J. (2021). Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL). Blood, 138(Supplement 1), 3534–3534. https://doi.org/10.1182/blood-2021-148779

Horwitz, S. M., Foran, J. M., Maris, M., Lue, J. K., Sawas, A., Okada, C., Feldman, T. A., Sokol, L., Mei, M., Flinn, I. W., Villa, D., Percival, M.-E. M., Jagadeesh, D., Savage, K. J., Akilov, O., Diefenbach, C. S., Kim, Y. H., Lin, G. H. Y., Catalano, T., … Ansell, S. M. (2021). Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies. Blood, 138(Supplement 1), 2448–2448. https://doi.org/10.1182/blood-2021-154490

Shen, B. (2020). Endoscopic band ligation with hypertonic glucose cushion in the treatment of ileal pouch prolapse. Gastroenterology Report, 9(5), 480–482. https://doi.org/10.1093/gastro/goaa089

Blackett, J. W., Wainberg, M., Elkind, M. S. V., & Freedberg, D. E. (2022). Potential Long Coronavirus Disease 2019 Gastrointestinal Symptoms 6 Months After Coronavirus Infection Are Associated With Mental Health Symptoms. Gastroenterology, 162(2), 648-650.e2. https://doi.org/10.1053/j.gastro.2021.10.040

Carelli, V., Hirano, M., Enríquez, J. A., & Chinnery, P. F. (2021). Implications of mitochondrial DNA mutations in human induced pluripotent stem cells. Nature Reviews Genetics, 23(2), 69–70. https://doi.org/10.1038/s41576-021-00430-z

Nativi-Nicolau, J., Siu, A., Dispenzieri, A., Maurer, M. S., Rapezzi, C., Kristen, A. V., Garcia-Pavia, P., LoRusso, S., Waddington-Cruz, M., Lairez, O., Witteles, R., Chapman, D., Amass, L., Grogan, M., Barroso, F. A., Van Cleemput, J., Fine, N., Schmidt, H., Gess, B., … Mueller, C. (2021). Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. JACC: CardioOncology, 3(4), 537–546. https://doi.org/10.1016/j.jaccao.2021.08.009

Roeker, L. E., Eyre, T. A., Thompson, M. C., Lamanna, N., Coltoff, A. R., Davids, M. S., Baker, P. O., Leslie, L., Rogers, K. A., Allan, J. N., Cordoba, R., Lopez-Garcia, A., Antic, D., Pagel, J. M., Martinez-Calle, N., García-Marco, J. A., Hernández-Rivas, J.-Á., Miras, F., Coombs, C. C., … Mato, A. R. (2021). COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood, 138(18), 1768–1773. https://doi.org/10.1182/blood.2021011841

Devineni, A. V., Deere, J. U., Sun, B., & Axel, R. (2021). Individual bitter-sensing neurons in Drosophila exhibit both ON and OFF responses that influence synaptic plasticity. Current Biology, 31(24), 5533-5546.e7. https://doi.org/10.1016/j.cub.2021.10.020